ストックスクリーナーアプリを入手
1.8124
5.26%
-0.0876
前日終値:
$1.90
開ける：
$1.85
24時間の取引高:
250.38K
Relative Volume:
1.17
時価総額：
$29.13M
収益：
-
当期純損益:
$-8.29M
株価収益率:
-2.5891
EPS:
-0.7
ネットキャッシュフロー:
$-6.47M
1週間 パフォーマンス:
+8.43%
1か月 パフォーマンス:
+26.76%
6か月 パフォーマンス:
+45.16%
1年 パフォーマンス:
+20.81%
1日の値動き範囲:
$1.76
$1.92
1週間の範囲:
$1.65
$2.2299
52週間の値動き範囲:
$0.94
$2.2299
NanoViricides Inc Stock (NNVC) Company Profile
NNVC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.8124 | 33.12M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.02 | 105.61B | 11.74B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
646.91 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.46 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.87 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.33 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-02-11 | 開始されました | Midtown Partners | Strong Buy |
NanoViricides Inc (NNVC) 最新ニュース
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd - Bergen Record
How to use Fibonacci retracement on NanoViricides Inc.2025 Macro Impact & Weekly Momentum Stock Picks - newser.com
Why NanoViricides Inc. stock is upgraded to buy2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
How to build a dashboard for NanoViricides Inc. stockJuly 2025 News Drivers & AI Forecast Swing Trade Picks - newser.com
NanoViricides’ NV-387 shows broad antiviral potential, says Zacks - Proactive financial news
Has NanoViricides Inc. found a price floorJuly 2025 Trends & Fast Gaining Stock Strategy Reports - newser.com
Is NanoViricides Inc. stock a defensive play amid uncertaintyMarket Growth Summary & Real-Time Volume Analysis - newser.com
How NanoViricides Inc. stock trades after earningsEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Can NanoViricides Inc. stock hit consensus price targetsShort Setup & Long Hold Capital Preservation Plans - newser.com
NanoViricides to Present at the PODD 2025 Conference in Boston on October 27 - Springfield News-Leader
Combining machine learning predictions for NanoViricides Inc.CEO Change & Verified Technical Signals - newser.com
Why NanoViricides Inc. stock appeals to dividend seekersWeekly Risk Report & AI Powered Market Entry Strategies - newser.com
NanoViricides Sets 2025 Annual Shareholders Meeting Amid Clinical Development Push - citybuzz -
How NanoViricides Inc. (NV3P) stock trades after rate cutsTrade Performance Summary & Fast Exit and Entry Strategy Plans - newser.com
Can NanoViricides Inc. (NV3P) stock ride next bull market cycleCEO Change & Weekly Watchlist for Hot Stocks - newser.com
Will NanoViricides Inc. stock benefit from sector leadershipJuly 2025 WrapUp & Expert-Curated Trade Recommendations - fcp.pa.gov.br
Why NanoViricides Inc. stock is a must watch in 2025Portfolio Return Summary & Real-Time Volume Analysis - fcp.pa.gov.br
NanoViricides Annual Shareholders Meeting to be Held at 10 am on Saturday, November 5th at on Saturday, November 8, 2025, at the Hampton Inn & Suites Stamford, CT - Lelezard
Will NanoViricides Inc. stock split attract more investors2025 Trade Ideas & Consistent Growth Equity Picks - newser.com
Is NanoViricides Inc. stock undervalued vs historical averages2025 Growth vs Value & AI Enhanced Trading Signals - newser.com
Identifying reversal signals in NanoViricides Inc.July 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Using portfolio simulators with NanoViricides Inc. includedQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - The Northwest Florida Daily News
In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides - Herald Times Reporter
NanoViricides to Present Antiviral Drug Pipeline at Spartan Capital Investor Conference - citybuzz -
NanoViricides (NYSE American: NNVC) to present 09:45 ET at Spartan Capital Conference 2025 - Stock Titan
NanoViricides to present at Spartan Capital Investor Conference 2025 in New York - Proactive financial news
NanoViricides Inc (NNVC) 財務データ
収益
当期純利益
現金流量
EPS
5.42%
0.06%
大文字化:
|
ボリューム (24 時間):